Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 17.4% on an

Hims & Hers Health Inc (NYSE:HIMS) shares are rising on Wenesday after B of A Securities and Ca

Hims & Hers Health shares (HIMS) surged 9% on Wednesday after Canaccord Genuity raised its price tar

HIMS facing negative impact on peptide optionality due to FDA's recommendation against adding 7

Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes

Canaccord Genuity analyst Maria Ripps maintains Hims & Hers Health (NYSE:HIMS) with a Buy and

B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE:HIMS) with a Neutral

In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $33.39, indicating a -

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Him

The Medicare GLP-1 Bridge program will be the first time eligible Medicare Part D patients will be a

Telehealth provider Hims and Hers Health may get a boost next year from employers dropping coverage

Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 14.14% on an

As demand for GLP-1 medications continues to increase across the U.S., CVS Health® (NYSE:CVS) today

Hims & Hers Health (NYSE: HIMS) shares are climbing after Barclays reiterated its bullish stance

Barclays analyst Glen Santangelo maintains Hims & Hers Health (NYSE:HIMS) with a Overweight a

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher on Tuesday as the stock continues t

Hims & Hers shares are jumping Monday afternoon, staging a sharp rebound after a wave of profit-

Hims & Hers Health is trading lower Friday as stock digests CMO appointment and gives back repai

Hims & Hers Health shares are trading higher on Tuesday as investors react to a new chief medica

Shares of Hims & Hers Health are trading higher on Thursday as investors react to a new chief me

These changes build on Caremark's industry leading efforts as a pharmacy benefits manager to exp

Shares of Hims & Hers Health Inc (NYSE: HIMS) are trading higher Wednesday morning after insider

B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE:HIMS) with a Neutral

Benzinga examined the prospects for many investors' favorite stocks over the last week — here&#3

Truist Securities analyst Jailendra Singh maintains Hims & Hers Health (NYSE:HIMS) with a Hol

Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced

Hims & Hers Health is trading flat on Wednesday as the stock continues to digest financing-relat

B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE:HIMS) with a Neutral

Hims & Hers Health (NYSE: HIMS) shares are trading flat in Tuesday's pre-market as traders c

Proceeds intended to be used to preserve financial flexibility as Hims & Hers executes on its in

HIMS shares drop 8% as Hims & Hers announces a $300M convertible notes offering, fueling investo

Hims & Hers also expects to grant the initial purchasers of the notes an option to purchase, for

Top Wall Street analysts updated their ratings on top companies. For full list of changes, including

B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE:HIMS) with a Neutral

Citigroup analyst Daniel Grosslight maintains Hims & Hers Health (NYSE:HIMS) with a Neutral a

Nasdaq 100 sinks as April CPI hits 3.8%; Sandisk, Micron and Intel each lose roughly 9% while the 30

Hims & Hers Health shares tank after disappointing Q1 results. Company raised 2026 revenue outlo

JP Morgan analyst Cory Carpenter maintains Hims & Hers Health (NYSE:HIMS) with a Overweight a

HIMS shares fell 14% in premarket trading after Q1 earnings and revenue missed Wall Street estimates

U.S. stock futures lower, Nasdaq down 200 points. AST SpaceMobile shares dip 11% after reporting wor

Needham analyst Ryan MacDonald maintains Hims & Hers Health (NYSE:HIMS) with a Buy and raises

Harmonic Inc (HLIT) rose in pre-market trading after beating earnings expectations & raising gui

Hims & Hers Health report Q1 results, missing revenue estimates but increasing subscribers. Stoc

Hims & Hers Health (NYSE:HIMS) raises FY2026 sales outlook from $2.700 billion-$2.900 billion to